Daniel P. Stefanko

Daniel P. Stefanko

Auto-generated profile, based on publicly available information

Daniel P. Stefanko

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Case Reports in Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
DSDaniel P Stefanko
Daniel P Stefanko
RERamez Eskander
Ramez Eskander
OAOmonigho Aisagbonhi
Omonigho Aisagbonhi
Morcellation of benign uterine tumors allows for removal of the tumors via minimally invasive laparoscopic procedures. However, in rare cases, morcellation has been associated with upstaging of unexpected malignancies. Morcellation has also been associated with dissemination of benign pathologic processes such as endometriosis and leiomyomas. Endometrial stromal sarcoma typically arises in the uterine cavity, although cases of extrauterine endometrioid stromal sarcoma arising out of foci of endometriosis have been reported. Dissemination of endometrial stromal sarcomas can be an unintended consequence of morcellation procedures, as can dissemination of endometriosis, from which endometrioid stromal sarcomas can arise. Herein, we report a case of a 55‐year‐old woman who was found to have disseminated endometriosis and low‐grade endometrioid stromal sarcoma, with bowel and liver parenchymal metastasis, 7 years after undergoing supracervical hysterectomy with unconfined uterine morcellation for adenomyosis. Our case highlights the potential for malignant transformation of disseminated adenomyosis/endometriosis and the importance of patient counseling and shared decision‐making prior to morcellation procedures.

24 November 2025 in Environment International
Verified
Journal Article
Open access
Rajat GuptaRajat Gupta
Rajat Gupta
CCCandace Chang
Candace Chang
DGDavid H. Gonzalez
David H. Gonzalez
PSPriyansha Srivastava
Priyansha Srivastava
CLCollin Le
Collin Le
JAJesus Antonio Araujo
Jesus Antonio Araujo
Air pollution exposure is associated with increased cardiovascular morbidity and mortality worldwide. Previous studies provide a causal relationship between exposure to particulate matter (PM) and atherosclerosis development. We have previously demonstrated increased aortic atherosclerosis and adverse metabolic effects in hyperlipidemic mice exposed to ambient ultrafine PM. However, the underlying mechanisms by which ambient PM promotes systemic effects leading to worsened atherosclerosis remain unknown. We have recently shown that the gut microbiota composition was altered in mice exposed to re-aerosolized PM in the ultrafine-size range for 10 weeks. We hypothesized that sub-chronic exposure to ultrafine PM induces gut dysbiosis in association with systemic prooxidative effects and atherosclerotic lesion development. Male apolipoprotein E knockout (ApoE-/-) mice were fed a chow diet and exposed to re-aerosolized PM, highly enriched in particles in the ultrafine-size range (ultrafine PM) vs. filtered air (FA) by inhalation (6 h/day, 3 days/week for 10 weeks). Ultrafine PM-exposed mice exhibited marked differences in the gut microbiota composition, which significantly associated with worsened atherosclerotic lesions in the innominate artery and aorta. Ultrafine PM-exposed mice also displayed significantly elevated levels of short chain fatty acids (SCFAs) in the feces, malondialdehyde (MDA) content in the liver and upregulation of hepatic antioxidant and endoplasmic reticulum (ER) stress response genes, all of which correlated with changes in the gut microbiota composition. In conclusion, inhaled PM in the ultrafine-size range induced changes in the gut microbiota composition and its metabolites, which correlated with systemic prooxidative effects, hepatic ER stress and worsened atherosclerosis.

1 November 2020 in AJSP: Reviews and Reports
Verified
Journal Article
Open access
DSDaniel P. Stefanko
Daniel P. Stefanko
GLGrace Y Lin
Grace Y Lin
RORyan K. Orosco
Ryan K. Orosco
VVVera Vavinskaya
Vera Vavinskaya
Mesothelial cell inclusions in cervical lymph nodes are of exceedingly rare occurrence and can be mistaken for metastatic adenocarcinoma. We report the case of a 27-year-old woman with a history of chronic myelogenous leukemia, diagnosed at age 5 years, and a recent diagnosis of alveolar soft part sarcoma of the left parotid gland. The patient underwent a left parotidectomy and neck dissection with intraoperative finding of abnormal lymph nodes in levels II to V. Histological examination revealed clusters of bland cells with pseudoglandular formation in 6 of 14 level IV/V lymph nodes. Immunological stains were consistent with mesothelial origin, and the diagnosis of benign mesothelial cell inclusions was made. Recognition of this entity in the evaluation of lymph nodes is important to prevent misdiagnosis of metastatic disease, particularly in a patient with multiple known malignancies.

2 September 2026
Verified
Other
Open access
KAKelley E. Anderson
Kelley E. Anderson
LTLinh M. Tran
Linh M. Tran
KKKostyantyn Krysan
Kostyantyn Krysan
YKYohana Kefella
Yohana Kefella
LYLingge Yu
Lingge Yu
JBJennifer Beane
Jennifer Beane
Presence of TP53 driver mutations stratified by histology in Lung PCA data.

2 September 2026
Verified
Other
Open access
KAKelley E. Anderson
Kelley E. Anderson
LTLinh M. Tran
Linh M. Tran
KKKostyantyn Krysan
Kostyantyn Krysan
YKYohana Kefella
Yohana Kefella
LYLingge Yu
Lingge Yu
JBJennifer Beane
Jennifer Beane
Lung PCA histology groups stratified by archetype.

2 September 2026
Verified
Other
Open access
KAKelley E. Anderson
Kelley E. Anderson
LTLinh M. Tran
Linh M. Tran
KKKostyantyn Krysan
Kostyantyn Krysan
YKYohana Kefella
Yohana Kefella
LYLingge Yu
Lingge Yu
JBJennifer Beane
Jennifer Beane
Projection of archetypes into cancer data stratifies cohorts by lesion features and prognosis. A, Scatterplot of first two PCs computed from GSVA scores for PML-derived modules in the full Lung PCA cohort, with annotated projection of PML archetypes into the Lung PCA PC space. Samples in the top 0.125 proportion of distances from each archetype were assigned archetypes, whereas other samples were labeled as “secondary,” with colors representing samples closest to each respective archetype. Shapes designate sample histology. B, Visualization of χ2 residuals from χ2 test of association of archetypes with histology in Lung PCA samples. Plot shows contribution of each cell to the test statistic, in which circle size is proportional to cell contribution. Positive (red) values specify a positive association between the corresponding row and column variables (P = 0.00053). C–E, Heatmap of t-statistics for linear models testing the association between distance from each archetype (columns) and tumor histologic pattern (rows), *, P < 0.05, for: C, Lung PCA tumor samples (linear mixed-effects models with histologic pattern and stage as fixed effects and patient as a random effect). D, GSE166720 tumor samples (linear models with histologic pattern as a fixed effect) and (E) TRACERx tumor samples, with histology indicating overall histology of tumor (linear mixed-effects models with histologic pattern and stage as fixed effects and patient as a random effect). F and G, Kaplan Meier curves stratified by archetype with Cox proportional-hazards model used to estimate disease-free survival probability for samples closest to each archetype in F. TRACERx stage I tumor samples (n = 158 samples, n = 77, patients, n = 100 secondary, n = 20 normal-like, n = 21 inflammation, n = 7 cell adhesion, n = 10 proliferation, Cox proportional-hazards model, P = 0.00016, HR = 4.50 for samples assigned to proliferation archetype). G, GSE31210 stage I tumor samples (n = 168 samples, n = 168 patients, n = 92 secondary, n = 27 normal-like, n = 23 inflammation, n = 11 cell adhesion, n = 15 proliferation, Cox proportional-hazards model, P = 0.00027, HR = 4.12 for samples assigned to proliferation archetype).